Chattem, Inc. (NASDAQ:CHTT)
CAPS Rating:
Marketer and manufacturer of a broad portfolio of branded over-the-counter healthcare products, toiletries and dietary supplements including such categories as topical analgesics, medicated skin care products, medicated dandruff shampoos and conditioners.
RSS Headlines
Fool UK
Recs
Love the stock (I know, one should never fall in love with a stock). Have owned since $30, but market over-reacted to great news that they were buying a few brands from JNJ, and CHTT rocketed to $40, which I believe is near-term over-bought. Buy on a pullback to under $35.